Friday, 16 September 2016

In Vivo Anti-diabetic and Biological Activities of Milk Protein and Milk Protein Hydrolyaste

Type 2 diabetes mellitus is a public health crisis that affects the economies of the world, especially developing countries. The worldwide incidence of type 2 diabetes is increasing. It was estimated in 2000 that there were 171 million diabetics. This will reach to 366 million people in 2030. In 2003 the expert committee of the American diabetes association proposed to eliminate the terms insulin and non-insulindependent diabetes mellitus and their acronyms (IDDM and NIDDM).

Milk Protein Hydrolyaste
Type 1 diabetes is actually known as IDDM. Type 2 diabetes is a heterogeneous clinical syndrome characterized by elevated blood glucose levels due to defective insulin secretion and/or insulin action, so this type known as NIDDM. When insulin secretion cannot compensate for insulin resistance, type 2 diabetes develops.Milk proteins are considered to be the most important sources of bioactive peptides. The beneficial health effects of milk bioactive peptides are classified as cytomodulatory, mineral binding, antimicrobial, immunomodulatory, blood-pressure lowering (Angiotensinconverting enzyme, ACE-inhibitory), antithrombotic, antioxidant and opioid like, in addition to cholesterol-lowering.

Bioactive peptides released from milk proteins in the gastrointestinal tract by the action of digestive enzymes such as pepsin, trypsin, chymotrypsin, carboxy and aminopeptidases. The physiological activity of bioactive peptides depends on their ability to maintain integral state during transport to the various functional systems of the body.


No comments:

Post a Comment